Ghiath M. Sukhtian serves as Executive at Oncobiologics, Inc., where they oversee executive responsibilities. Since joining the company, Ghiath M. Sukhtian has executed 11 insider transactions totaling $20.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 18, 2024 involved receiving (via award) 2,305,714 shares valued at $0.
Ghiath M. Sukhtian currently holds 5,808,074 shares of Oncobiologics, Inc. (ONS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ghiath M. Sukhtian has been a net buyer of ONS stock. They have purchased $20.0M and sold $0 worth of shares.
Ghiath M. Sukhtian's most recent insider trade was on Mar 18, 2024, when they sold 2,305,714 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.88 |
| Discretionary |
| Apr 21, 2022 | OTLK | $0 | Other | 27,982,529 | $N/A | Discretionary |
| Nov 29, 2021 | OTLK | $20.0M | Purchase | 16,000,000 | $1.25 | Discretionary |
| Feb 10, 2021 | OTLK | $1.0M | Award | 1,013,627 | $1.00 | Discretionary |
| Feb 26, 2020 | OTLK | $2.5M | Award | 2,460,630 | $1.02 | Discretionary |
| Jan 29, 2020 | OTLK | $1.1M | Option Exercise | 4,657,852 | $0.23 | Discretionary |
| Apr 12, 2019 | OTLK | $10.0M | Award | 3,636,364 | $2.75 | Discretionary |
| Jun 20, 2018 | ONS | $0 | Conversion | 31,572,617 | $N/A | Discretionary |
| Jun 8, 2018 | ONS | $6.2M | Award | 6,377,383 | $0.98 | Discretionary |
| May 14, 2018 | ONS | $6.2M | Award | 6,377,383 | $0.98 | Discretionary |